These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8154389

  • 1. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes].
    Yamazaki Y, Miyamoto S, Sawa M.
    Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):293-7. PubMed ID: 8154389
    [Abstract] [Full Text] [Related]

  • 2. [The time required topical carbonic anhydrase inhibitor (MK-507) to take effect on intraocular pressure of normal human eyes].
    Nakagami T, Yamazaki Y, Miyamoto S, Sawa M.
    Nippon Ganka Gakkai Zasshi; 1995 Sep; 99(9):1022-5. PubMed ID: 7484502
    [Abstract] [Full Text] [Related]

  • 3. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
    Yamazaki Y, Miyamoto S, Sawa M.
    Jpn J Ophthalmol; 1994 Sep; 38(1):92-6. PubMed ID: 7933704
    [Abstract] [Full Text] [Related]

  • 4. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 5. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM.
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [Abstract] [Full Text] [Related]

  • 6. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF, Maren TH.
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [Abstract] [Full Text] [Related]

  • 7. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.
    Wang RF, Serle JB, Podos SM, Surgrue MF.
    Curr Eye Res; 1990 Feb; 9(2):163-8. PubMed ID: 2335112
    [Abstract] [Full Text] [Related]

  • 8. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Cawrse MA, Ward DA, Hendrix DV.
    Am J Vet Res; 2001 Jun; 62(6):859-63. PubMed ID: 11400841
    [Abstract] [Full Text] [Related]

  • 9. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
    Vanlandingham BD, Maus TL, Brubaker RF.
    Ophthalmology; 1998 Aug; 105(8):1537-40. PubMed ID: 9709770
    [Abstract] [Full Text] [Related]

  • 10. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL, Larsson LI, McLaren JW, Brubaker RF.
    Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424
    [Abstract] [Full Text] [Related]

  • 11. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys.
    Wang RF, Serle JB, Podos SM, Sugrue MF.
    Arch Ophthalmol; 1991 Sep; 109(9):1297-9. PubMed ID: 1929960
    [Abstract] [Full Text] [Related]

  • 12. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM, Challa P, Maren TH.
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [Abstract] [Full Text] [Related]

  • 13. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N, Grehn F, Hennekes R, Garus H.
    Fortschr Ophthalmol; 1990 Feb; 87(2):128-30. PubMed ID: 2192972
    [Abstract] [Full Text] [Related]

  • 14. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Feb; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 15. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
    Maren TH, Bar-Ilan A, Conroy CW, Brechue WF.
    Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
    [Abstract] [Full Text] [Related]

  • 16. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
    [Abstract] [Full Text] [Related]

  • 17. [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands].
    Feicht B, Hofmann HM, Lippa E, Brunner-Ferber F, von Denffer H, Merté HJ.
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):254-7. PubMed ID: 2255169
    [Abstract] [Full Text] [Related]

  • 18. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide.
    Larsson LI, Alm A.
    Arch Ophthalmol; 1998 Jan; 116(1):19-24. PubMed ID: 9445204
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC, Gum GG, Gelatt KN.
    Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
    [Abstract] [Full Text] [Related]

  • 20. Effect of dorzolamide on corneal endothelial function in normal human eyes.
    Egan CA, Hodge DO, McLaren JW, Bourne WM.
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):23-9. PubMed ID: 9430541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.